Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Evelyn Findlay"'
Autor:
Isla S Mackenzie, Ian Ford, George Nuki, Jesper Hallas, Christopher J Hawkey, John Webster, Stuart H Ralston, Matthew Walters, Michele Robertson, Raffaele De Caterina, Evelyn Findlay, Fernando Perez-Ruiz, John J V McMurray, Thomas M MacDonald, J. Aziz, G. Dobson, A.S.F. Doney, R.W.V. Flynn, J. Furnace, J.W.K. Grieve, G. Guthrie, D. Jamieson, C.G. Jennings, S. Kean, L.C. Lund, A. McConnachie, F. Pigazzani, P.L. Riches, M. Rix Hanson, A Rogers, E.D.M. Rooke, J. Thomson, M. Warren, K. Wetherall, R. Wilson, C.P. Hall, A. Maseri, H.A. Bird, G. Murray, J.W. Dear, M. Petrie, M. MacDonald, P.S. Jhund, E. Connolly, D.J. Murphy, N. Paul, A. Olsson, P.T. Koskinen, A. Fuat, A. Foster, W. Saywood, R.J. Barr, L. McConnachie, L.F. Wilson, L. Larsen Rasmussen, A.R. McGinnis, H. Birrell, M. Keiller, I.S. Bremner, G.J. Forbes, J.S. Dumbleton, J. Rhodes, T. Waller
Publikováno v:
Mackenzie, I S, Ford, I, Nuki, G, Hallas, J, Hawkey, C J, Webster, J, Ralston, S H, Walters, M, Robertson, M, De Caterina, R, Findlay, E, Perez-Ruiz, F, McMurray, J J V, MacDonald, T M & FAST Study Group 2020, ' Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST) : a multicentre, prospective, randomised, open-label, non-inferiority trial ', The Lancet, vol. 396, no. 10264, pp. 1745-1757 . https://doi.org/10.1016/S0140-6736(20)32234-0
2020, ' Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial ', The Lancet, vol. 396, no. 10264, pp. 1745-1757 . https://doi.org/10.1016/S0140-6736(20)32234-0
2020, ' Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial ', The Lancet, vol. 396, no. 10264, pp. 1745-1757 . https://doi.org/10.1016/S0140-6736(20)32234-0
Background:\ud Febuxostat and allopurinol are urate-lowering therapies used to treat patients with gout. Following concerns about the cardiovascular safety of febuxostat, the European Medicines Agency recommended a post-licensing study assessing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142bbff4688747cdc863c81cac8cac4b
https://findresearcher.sdu.dk:8443/ws/files/178292702/FAST_Lancet_manuscript_updated_191020_FINAL.pdf
https://findresearcher.sdu.dk:8443/ws/files/178292702/FAST_Lancet_manuscript_updated_191020_FINAL.pdf
Autor:
Neil R Poulter, Morris J. Brown, David J. Webb, Thomas M. MacDonald, Evelyn Findlay, Greg Guthrie, Isla S. Mackenzie, Bryan Williams, Chim C. Lang, Ian Ford
Publikováno v:
Guthrie, G, Poulter, Macdonald, T, Ford, I, Mackenzie, I, Findlay, E, Williams, B, Brown, M, Lang, C & Webb, D 2020, ' Chronotherapy in hypertension: the devil is in the details ', European Heart Journal, vol. 41, no. 16, pp. 1606-1607 . https://doi.org/10.1093/eurheartj/ehaa265
This commentary refers to ‘Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial’, by R.C. Hermida et al., doi:10.1093/eurheartj/ehz754.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea816b3dd644f8f8bf7b69dcd4a0be70
https://pubmed.ncbi.nlm.nih.gov/32306035
https://pubmed.ncbi.nlm.nih.gov/32306035
Autor:
Isla S. Mackenzie, Thomas M. MacDonald, Li Wei, Evelyn Findlay, Daniel Rutherford, Marion K Campbell, Wendy Saywood
Publikováno v:
British Journal of Clinical Pharmacology
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Recruitment is key to the success of clinical trials. * Many clinical trials fail to achieve adequate recruitment. * Public understanding and engagement in clinical research could be improved. WHAT THIS STUD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae479cf5ba90b9a7dedc1b0f4828427
https://doi.org/10.1111/j.1365-2125.2009.03561.x
https://doi.org/10.1111/j.1365-2125.2009.03561.x
Autor:
Neil R Poulter, Ian Ford, Isla S. Mackenzie, Bryan Williams, David A. Rorie, Morris J. Brown, Thomas M. MacDonald, Evelyn Findlay, David J. Webb, Amy Rogers
Publikováno v:
Journal of Clinical Trials.
Aims: The Treatment in Morning versus Evening (TIME) pilot study sought to establish the feasibility of an onlineonly study detecting whether evening dosing of antihypertensives is more cardio protective than morning dosing. Methods: The TIME study u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d1a2a62f8aae6e92729f1270ee44ff3
https://doi.org/10.4172/2167-0870.1000281
https://doi.org/10.4172/2167-0870.1000281